Dirk Jan Reijngoud

Dirk Jan Reijngoud is a Professor active in the fields of Biochemistry, Molecular Biology, and Metabolism, with a focus on lipid metabolism, prebiotics, and tumor metabolic pathways.

• Contributing to global health via research aligned with UN Sustainable Development Goals (SDGs), particularly those related to health and well-being.

His work explores mitochondrial function, insulin sensitivity, and prebiotic fermentation, often in collaboration with researchers like Bakker B.M., Gerding A., and Hooiveld G.J.. Key trends include modeling metabolic disorders and optimizing cancer therapies through metabolic regulation.

Recent publications highlight:

• Mechanistic insights into β-oxidation kinetics in the liver (2025).
• Prebiotic fructo/galacto-oligosaccharides and their impact on human intestinal health (2024).
• Metabolic effects of Everolimus in breast cancer (2024).
• Targeting tumor metabolism to improve melanoma immunotherapy (2024).

He has contributed to 148 research outputs and 11 datasets, often through repositories like figshare and DataverseNL, with collaborations spanning institutions and disciplines.